102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | Lupus Science and Medicine |
| _version_ | 1828090550907043840 |
|---|---|
| author | Joan T Merrill Michelle Petri David A Isenberg Daniel J Wallace Susan Manzi Cynthia Aranow Jill Buyon Rosalind Ramsey-Goldman Anca Askanase Ian N Bruce Guillermo Ruiz-Irastorza Ellen M Ginzler Graciela S Alarcón John G Hanly Murray B Urowitz Juanita Romero-Diaz Caroline Gordon Sang-Cheol Bae Anisur Rahman Mary Anne Dooley Paul R Fortin Dafna D Gladman Meggan Mackay Andreas Jönsen Sam Lim Murat Inanc Diane L Kamen Christine A Peschken Søren Jacobsen Jorge Sanchez-Guerrero Marvin J Fritzler Ann E Clarke Sasha Bernatsky Kenneth C Kalunian Eugene Krustev May Y Choi Ronald F van Vollenhoven Katherine Buhler Ricky Chin Francesca Cardwell |
| author_facet | Joan T Merrill Michelle Petri David A Isenberg Daniel J Wallace Susan Manzi Cynthia Aranow Jill Buyon Rosalind Ramsey-Goldman Anca Askanase Ian N Bruce Guillermo Ruiz-Irastorza Ellen M Ginzler Graciela S Alarcón John G Hanly Murray B Urowitz Juanita Romero-Diaz Caroline Gordon Sang-Cheol Bae Anisur Rahman Mary Anne Dooley Paul R Fortin Dafna D Gladman Meggan Mackay Andreas Jönsen Sam Lim Murat Inanc Diane L Kamen Christine A Peschken Søren Jacobsen Jorge Sanchez-Guerrero Marvin J Fritzler Ann E Clarke Sasha Bernatsky Kenneth C Kalunian Eugene Krustev May Y Choi Ronald F van Vollenhoven Katherine Buhler Ricky Chin Francesca Cardwell |
| author_sort | Joan T Merrill |
| collection | DOAJ |
| first_indexed | 2024-04-11T05:58:23Z |
| format | Article |
| id | doaj.art-3027681b999c4515b39409984366f051 |
| institution | Directory Open Access Journal |
| issn | 2053-8790 |
| language | English |
| last_indexed | 2024-04-11T05:58:23Z |
| publishDate | 2022-12-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Lupus Science and Medicine |
| spelling | doaj.art-3027681b999c4515b39409984366f0512022-12-22T04:41:48ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-12-019Suppl 310.1136/lupus-2022-lupus21century.2102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception CohortJoan T Merrill0Michelle Petri1David A Isenberg2Daniel J Wallace3Susan Manzi4Cynthia Aranow5Jill Buyon6Rosalind Ramsey-Goldman7Anca Askanase8Ian N Bruce9Guillermo Ruiz-Irastorza10Ellen M Ginzler11Graciela S Alarcón12John G Hanly13Murray B Urowitz14Juanita Romero-Diaz15Caroline Gordon16Sang-Cheol Bae17Anisur Rahman18Mary Anne Dooley19Paul R Fortin20Dafna D Gladman21Meggan Mackay22Andreas Jönsen23Sam Lim24Murat Inanc25Diane L Kamen26Christine A Peschken27Søren Jacobsen28Jorge Sanchez-Guerrero29Marvin J Fritzler30Ann E Clarke31Sasha Bernatsky32Kenneth C Kalunian33Eugene Krustev34May Y Choi35Ronald F van Vollenhoven36Katherine Buhler37Ricky Chin38Francesca Cardwell394 Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USARheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA9 Centre for Rheumatology Research, Department of Medicine, University College, London, UKDivision of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USAMedicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USAAutoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USADivision of Rheumatology, Department of Medicine, New York University School of Medicine, New York, USARheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA2 Rheumatology, Columbia University College of Physicians and Surgeons, New York, New York, USAThe Kellgren Centre for Rheumatology, NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UKAutoimmune Diseases Research Unit, BioCruces Bizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain14 Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USAHeersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA13 Medicine and Pathology, Queen Elizabeth ll Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, CanadaMedicine, University of Toronto, Toronto, Ontario, CanadaImmunology and Rheumatology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, MexicoRheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UKDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea (the Republic of)Medicine (Rheumatology), University College London, London, UK15 Thurston Arthritis Research Centre, University of North Carolina, Chapel Hill, NC, USA11 Division of Rheumatology, Department of Medicine, CHU de Québec, Université Laval, Quebec City, Quebec, Canada1 Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, CanadaInstitute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USALund University, Lund, SwedenRollins School of Public Health, Atlanta, Georgia, USAInternal Medicine Rheumatology, University of Istanbul, Istanbul, Turkey1 Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA27 University of Manitoba, Winnipeg, Manitoba, CanadaCopenhagen Research Center for Autoimmune Connective Tissue Diseases (COPEACT), Department of Rheumatology, Rigshospitalet, Copenhagen, DenmarkImmunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, MexicoMedicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, CanadaDivision of Rheumatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaDivisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, Québec, Canada25 UCSD School of Medicine, La Jolla, CA, USA1University of Calgary, Cumming School of Medicine, Calgary, Alberta, CanadaCumming School of Medicine, University of Calgary, Calgary, Alberta, Canada24University of Amsterdam, Rheumatology and Immunology Center, Amsterdam, Noord-Holland, NLMedicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, CanadaDivision of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada3University of Waterloo, Burlington, ON, Canada |
| spellingShingle | Joan T Merrill Michelle Petri David A Isenberg Daniel J Wallace Susan Manzi Cynthia Aranow Jill Buyon Rosalind Ramsey-Goldman Anca Askanase Ian N Bruce Guillermo Ruiz-Irastorza Ellen M Ginzler Graciela S Alarcón John G Hanly Murray B Urowitz Juanita Romero-Diaz Caroline Gordon Sang-Cheol Bae Anisur Rahman Mary Anne Dooley Paul R Fortin Dafna D Gladman Meggan Mackay Andreas Jönsen Sam Lim Murat Inanc Diane L Kamen Christine A Peschken Søren Jacobsen Jorge Sanchez-Guerrero Marvin J Fritzler Ann E Clarke Sasha Bernatsky Kenneth C Kalunian Eugene Krustev May Y Choi Ronald F van Vollenhoven Katherine Buhler Ricky Chin Francesca Cardwell 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort Lupus Science and Medicine |
| title | 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort |
| title_full | 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort |
| title_fullStr | 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort |
| title_full_unstemmed | 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort |
| title_short | 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort |
| title_sort | 102 m phase phosphoprotein 1 mpp 1 autoantibodies as a potential biomarker for cranial neuropathies in an international sle inception cohort |
| work_keys_str_mv | AT joantmerrill 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT michellepetri 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT davidaisenberg 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT danieljwallace 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT susanmanzi 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT cynthiaaranow 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT jillbuyon 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT rosalindramseygoldman 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT ancaaskanase 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT iannbruce 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT guillermoruizirastorza 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT ellenmginzler 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT gracielasalarcon 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT johnghanly 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT murrayburowitz 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT juanitaromerodiaz 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT carolinegordon 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT sangcheolbae 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT anisurrahman 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT maryannedooley 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT paulrfortin 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT dafnadgladman 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT megganmackay 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT andreasjonsen 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT samlim 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT muratinanc 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT dianelkamen 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT christineapeschken 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT sørenjacobsen 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT jorgesanchezguerrero 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT marvinjfritzler 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT anneclarke 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT sashabernatsky 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT kennethckalunian 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT eugenekrustev 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT mayychoi 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT ronaldfvanvollenhoven 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT katherinebuhler 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT rickychin 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort AT francescacardwell 102mphasephosphoprotein1mpp1autoantibodiesasapotentialbiomarkerforcranialneuropathiesinaninternationalsleinceptioncohort |